Princeton, NJ (PRWEB) September 16, 2013
The 5th annual DNA Innovation Summit kicks off today in Washington DC with a record number of attendees representing a cross-section of branded, generic, and specialty pharmaceutical manufacturers. The growth of this year’s user conference underscores the increasing importance of demand visibility, account management, and commerce optimization within the pharmaceutical industry.
The theme of this year’s Innovation Summit – the Value of 1% – is focused on ways for manufacturers to return revenue back to the bottom line by boosting product availability, maximizing distribution value, and improving forecast accuracy. Industry thought leaders and product experts will present a variety of sessions, case studies, product demonstrations, and benchmark reports centered on best practices in the forward supply chain. Attendees will gain valuable insight into ways of optimizing their demand networks and making the data they have more actionable.
DNA is a commerce optimization cloud that enables companies to increase sales, control distribution costs, and improve forecast accuracy by embedding customer insights in their daily business process. Through a combination of demand visibility, account management, and order management applications, the DNA suite provides manufacturers with an end-to-end view of a product’s distribution. This facilitates more streamlined distribution agreements, helping to avoid breakdowns in the forward supply chain and strengthening trading partner relationships.
For more information on the DNA commerce optimization suite, please visit http://www.integrichain.com.